Health
Lilly again far surpasses revenue expectations
Eli Lilly once again dominated revenue expectations, blowing past Wall Street's estimates by about $2 billion. The world's most valuable healthcare company posted $24.4 billion in third-quarter revenue, aided by what ...
- Published
- (1 h ago)
- Outlet
- Endpoints News
- Section
- Health
- Length here
- Headline and 32-word snippet. The full article is at the source.
More from Endpoints News and around the same time
Dren Bio raises $350M to get blood cancer drug onto market in 2027Dren Bio has raised $350 million, hoping to get its lead blood cancer drug onto the market by the end of 2027, the California drug developer exclusively told Endpoints News. The Thursday morning haul will ...Flagship Pioneering merges three of its companies for AI drug discoveryFlagship Pioneering is combining three of its portfolio companies, including one that has been around for a decade, in an effort to compete in the bustling AI drug discovery field. The Cambridge, MA-based incubator and ...Why Zocdoc is clearing the way for AI personal agentsAmazon, Delta Air Lines and major US banks have blocked people from using personal AI agents to shop, book flights and manage transactions. But as agents start handling patients' healthcare tasks, at least one company ...Formation Bio unveils $600M fund tied to existing modelFormation Bio, an AI-focused biotech that acquires outside assets, develops them and then hands them off, has raised a $600 million investment found to double down on that strategy. The new fund will help it ...FDA charts path for approval of individualized gene editing therapiesThe FDA has outlined steps drugmakers can take to seek regulatory approval for gene editing medicines tailored to fix a single person's disease-causing mutation. The announcement is part of an ongoing ...AstraZeneca’s bruising summer raises the stakes for 2027When one of AstraZeneca’s medicines, Wainua, failed a major late-stage heart disease trial in July, it was a jarring setback for a drugmaker whose research pipeline had become one of the most admired in the ...This page holds the headline and a short snippet as published by Endpoints News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
